Does RUXOLITINIB Cause Platelet count increased? 1,667 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,667 reports of Platelet count increased have been filed in association with RUXOLITINIB (OPZELURA). This represents 2.5% of all adverse event reports for RUXOLITINIB.
1,667
Reports of Platelet count increased with RUXOLITINIB
2.5%
of all RUXOLITINIB reports
92
Deaths
387
Hospitalizations
How Dangerous Is Platelet count increased From RUXOLITINIB?
Of the 1,667 reports, 92 (5.5%) resulted in death, 387 (23.2%) required hospitalization, and 42 (2.5%) were considered life-threatening.
Is Platelet count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 1,667 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Platelet count increased?
ELTROMBOPAG OLAMINE (980)
CLOZAPINE (745)
PREDNISONE (433)
ADALIMUMAB (404)
RITUXIMAB (400)
METHOTREXATE (356)
INFLIXIMAB (225)
OMALIZUMAB (223)
MONTELUKAST (211)
ALBUTEROL (200)
Which RUXOLITINIB Alternatives Have Lower Platelet count increased Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE